Sign in: Staff/Students
The University has been awarded more than £3m from the Engineering and Physical Sciences Research Council (EPSRC) for two research projects.
EPSRC is the main UK government agency for funding research and training in engineering and the physical sciences, investing more than £800 million a year in a broad range of subjects – from mathematics to materials science, and from information technology to structural engineering.
The grants, which have been awarded under EPSRC’s Healthcare Impact Partnerships scheme, will support two novel engineering and physical sciences projects that are aligned with healthcare and enable progression towards patient benefits in two highly important areas.
The first project, led by Professors Andrew Owen and Steve Rannard from the University’s Nanomedicine Partnership, is a collaboration between the University’s Department of Molecular and Clinical Pharmacology and the Department of Chemistry looking to progress novel materials and drug delivery through to adult human clinical trials.
The project seeks to validate a new polymeric material for drug delivery and improve the oral dosing of drugs through novel emulsion technologies. The approach is not limited to single drug class or disease and may impact large numbers of people with a variety of healthcare needs. The project has been awarded a grant worth £2,034,000.
The second project, led by Dr Victoria Kearns and Dr Tom McDonald, has been awarded a grant worth £1,050,000. This project is a collaboration between the University’s Department of Eye & Vision Science and Department of Chemistry looking to advance ophthalmic innovations, such as prolonged drug delivery to treat diseases of the back of the eye, to benefit a range of patients.
Professor Ken Badcock, Executive Pro Vice Chancellor for Science and Engineering, University of Liverpool, said: “This is an exciting time for research at the University of Liverpool. These projects build on our culture of innovation, strong community and outstanding facilities.
“These awards specifically recognise the strength and depth we already possess across our faculties of Science & Engineering and Health & Life Sciences, and will help further benefit the inter-disciplinary nature of our world-leading research.”
The Department of Molecular and Clinical Pharmacology is based in the University’s Institute of Translational Medicine, the Department of Eye and Vision Science is based in the University’s Institute of Ageing and Chronic Disease, and the Department of Chemistry is based in the University’s School of Physical Sciences.
To listen to Steve and Andrew’s podcast on nanomedicine please click here.
This grant does not cover the paediatric HIV therapy aspect of Professors Owen and Rannard’s work and the University is currently fundraising to support the advancement of this crucial project. For more details please visit: www.liverpool.ac.uk/giving/priorities/hiv
You must be logged in to post a comment.
All recent news
Daily testing saved city’s emergency services from Covid catastrophe
Large Hadron Collider takes first data in record-breaking run
Meet 10 Amazing #LivUniGrads
Liverpool physicists reflect on ten years since the Higgs boson discovery
New landmark £2.3m Liverpool-led clinical trial launched
New £2.3m trial aims to find out whether long-term #antibiotic treatment can reduce the impact that chest infections have on children with neurological impairment: https://news.liverpool.ac.uk/2022/07/04/new-landmark-2-3m-liverpool-led-clinical-trial-launched/
Postcard: @LivuniIPH urban food research draws the crowds at #Glastonbury➡️https://bit.ly/3ug65NS
Stalling improvements in #cardiovascular disease rates could cost UK £54bn, new @PLOSONE research suggests: https://news.liverpool.ac.uk/2022/06/29/stalling-improvements-in-cardiovascular-disease-rates-since-2010-could-cost-54bn-between-2020-and-2029/